Modern Meadow™s scientific team pioneered some of the technologies behind medical tissue engineering and invented a tissue engineering technique based on bioprinting, the 3D assembly of tissues driven by computer controlled processes. We are now applying the latest advances in tissue engineering to culture leather and meat without requiring the raising, slaughtering and transporting animals. From a technical perspective, our approaches integrate innovations in cell culture, biofabrication and bioreactors.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/27/14 | $10,000,000 | Series A | ||
| 06/28/16 | $40,000,000 | Series B |
Artis Ventures Breakout Ventures Collaborative Fund Horizons Ventures ICONIQ Capital Red Swan Ventures Temasek Tony Fadell | undisclosed |
